A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes

Trends in Pharmacological Sciences

Volumn 18, Issue 1, 1997, Pages 30-34

  Frolich J C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FLOSULIDE; IBUPROFEN; INDOMETACIN; ISOENZYME; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE INHIBITOR; SALICYLIC ACID;

ANTIINFLAMMATORY ACTIVITY; CLASSIFICATION; CLINICAL PHARMACOLOGY; DRUG SELECTIVITY; ENZYME INHIBITION; GASTROINTESTINAL TOXICITY; HUMAN; NEPHROTOXICITY; NONHUMAN; PHARMACOEPIDEMIOLOGY; PREDICTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIGESTIVE SYSTEM; ENZYME INDUCTION; HUMANS; ISOENZYMES; KIDNEY; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031034254     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)01017-6     Document Type: Review

References (55)

1. 1 Vane, J. R. (1971) Nature 231, 232-235
2. 2 Rosenkranz, B., Fischer, C. and Frölich, J. C. (1986) Br. J. Clin. Pharmacol. 21, 309-317
3. 3 Hardmann, J. G., Molinoff, P. and Ruddon, R., eds (1996) Goodman and Gilman's: The Pharmacological Basis of Therapeutics, McGraw-Hill
4. 4 Kalant, H. and Roschlau, W. H. E., eds (1989) Principles of Medical Pharmacology, B. C. Becker
5. 5 Forth, W., Henschler, D., Rummel, W. and Starke, K., eds (1992) Allgemeine und spezielle Pharmakologie und Toxikologie, BI-Wissenschaftsverlag
6. 6 Flower, R. J. and Blackwell, G. J. (1976) Biochem. Pharmacol. 25, 285-291
7. 7 Habenicht, A. J. et al. (1985) J. Clin. Invest. 75, 1381-1387
8. 8 Dennis, E. A. (1994) J. Biol. Chem. 269, 13057-13060
9. 9 Raz, A., Wyche, A., Siegel, N. and Needleman, P. (1988) J. Biol. Chem. 263, 3022-3025
10. 10 Raz, A., Wyche, A. and Needleman, P. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1657-1661
11. 11 Wong, W. Y. L. and Richards, J. C. (1991) Mol. Endocrinol. 5, 1269-1279
12. 12 Fu, J-Y. et al. (1990) J. Biol. Chem. 265, 16737-16740
13. 13 Masferrer, J. L. Zweifel, B. S., Seibert, K. and Needleman, P. (1990) J. Clin. Invest. 86, 1375-1379
14. 14 Xie, W. et al. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1692-1696
15. 15 Xie, W., Robertson, D. L. and Simmons, D. L. (1992) Drug Dev. Res. 25, 249-265
16. 16 Kraemer, K. W. et al. (1992) Arch. Biochem. Biophys. 293, 391-400
17. 17 O'Bannion, M. K., Winn, V. D. and Young, D. A. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4888-4892
18. 18 De Caterina, R., Gianessi, D., Gazzetti, P. and Bernini, W. (1985) Thromb. Res. 37, 337-342
19. 19 Lichtenstein, D. R., Syngal, S. and Wolfe, M. (1995) Arthritis Rheum. 38, 5-18
20. 20 Frölich, J. C. and Stichtenoth, D. O. (1996) in Improved Non-steroid Anti-inflammatory Drugs - COX-2 Enzyme Inhibitors (Vane, J. and Botting, R., eds), pp. 203-228, Kluwer Academic
21. 21 Harris, R. C. et al. (1994) J. Clin. Invest 94, 2504-2510
22. 22 Frölich, J. C. et al. (1979) Br. Med. J. 1, 1115-1116
23. 23 O'Neill, G. P. and Ford-Hutchinson, A. W. (1993) FEBS Lett. 330, 156-160
24. 24 Masferrer, J. L., Seibert, K., Zweifel, B. and Needleman, P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3917-3921
25. 25 Riese, J. et al. (1994) Leukocyte Biol. 55, 476-482
26. 26 Akarasereenont, P. et al. (1995) Eur. J. Pharmacol. 273, 121-128
27. 27 Wong, W. Y. L., DeWitt, D. L., Schmith, W. L. and Richards, J. S. (1989) Mol. Endocrinol. 3, 1714-1723
28. 28 Lee, S. H. et al. (1992) J. Biol. Chem. 267, 25934-25938
29. 29 O'Sullivan, M. G., Chilton, F. H., Huggings, E, M., Jr and McCall, C. P. (1992) J. Biol. Chem. 267, 14547-14550
30. 30 Hempel, S. L., Monick, M. and Hunninghake, G. W. (1994) J. Clin. Invest. 93, 391-396
31. 31 Arias-Negrette, S., Keller, K. and Chadee, K. (1995) Biochem. Biophys. Res. Commun. 208, 582-589
32. 32 Mertz, J. M., DeWitt, D. L., Stetler-Stevenson, W. G. and Wahl, L. M. (1994) J. Biol. Chem. 269, 21322-21329
33. 33 Crofford, L. J. et al. (1994) J. Clin. Invest. 93, 1095-1101
34. 34 Sano, H., Hla, T., Maier, J. A. M. and Crofford, L. J. (1992) J. Clin. Invest. 89, 97-108
35. 35 Meade, E. A., Smith, W. L. and DeWitt, D. L. (1993) J. Biol. Chem. 268, 6610-6614
36. 36 Mitchell, J. A. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 90, 11693-11697
37. 37 Laneuville, O. et al. (1994) J. Pharmacol. Exp. Ther. 271, 927-934
38. 38 Adams, L. Neuman, R. G., Sachs, J. and Bralow, S. P. (1990) Gastroenterology 98, A11
39. 39 Patrignani, P. et al. (1994) J. Pharmacol Exp. Ther. 271, 1705-1712
40. 40 Glaser, K. et al. (1995) Eur. J. Pharmacol. 281, 107-111
41. 41 Grossman, C. J. et al. (1995) Inflamm. Res. 44, 253-257
42. 42 Otto, J. C., deWitt, D. L., Schindler, M. S. and Smith, W. L. (1993) J. Biol. Chem. 268, 18234-18242
43. 43 Akarasereenont, P., Mitchell, J. A., Thiemermann, C. and Vane, J. R. (1994) Br. J. Pharmacol. 122 (Suppl.), 183P
44. 44 Vane, J. R. and Botting, R. M. (1996) in Improved Non-Steroid Anti-Inflammatory Drugs - COX-2 Enzyme Inhibitors (Vane, J. and Botting, R., eds), pp. 1-27, Kluwer Academic
45. 45 Appleton, I., Tomlinson, A., Colville-Nash, P. R. and Willoughby, D. A. (1993) Lab. Invest. 69, 405-414
46. 46 Engelhardt, G. et al. (1995) Inflamm. Res. 44, 423-433
47. 47 (1993) Physicians Desk Reference: Medical Economics Data, p. 1351, Montvale
48. 48 Henry D., Dobson, A. and Turner, C. (1993) Gastroenterology 10, 1078-1088
49. 49 Gabriel, S. E., Jaakkimeinen, L. and Bombardier, D. (1991) Ann. Intern. Med. 115, 787-796
50. 50 Churchill, L. et al. (1996) Inflammatology 4, 125-135
51. 51 Stichtenoth, D. O. et al. (1996) J. Invest. Med. 44, 297A
52. 52 Szczeklik, A. (1994) in Advances in Prostaglandin, Thromboxane and Leukotriene Research (Dahlén, S. E., ed.), pp. 185-198, Raven Press
53. 53 Garcia Rodriguez, L. A. and Jick, H. (1994) Lancet 343, 796-772
54. 54 Distel, M., Mueller, C., Bluhmki, E. and Fries, J. (1996) Brit. J. Rheumatol. 35, 68-77
55. 55 Dinchuk, J. et al. (1995) Nature 378, 406-409